Accelerating Breakthroughs in Genomics Research for Cancer, Drug Development and Precision Medicine

Summary

Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. The scalable, cloud-based Seven Bridges Platform empowers rapid, collaborative analysis of millions of genomes in concert with other forms of biomedical data. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. As the NIH’s only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world’s largest cancer genomics dataset. The company has offices in Cambridge, Mass., Belgrade; London and San Francisco.

CBTTC - One Word

The Children's Brain Tumor Tissue Consortium is transforming cancer research by using data to discover better treatments and cures for children diagnosed with pediatric brain tumors.
At each of the Children's Brain Tumor Tissue Consortium's member institutions, breakthroughs are made possible through the teamwork
and collaboration of doctors, researchers and patients.